Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite

Cited by (865)

Items 201–300 of 865

  1. Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: Critical influence of the drug introduction mode on the in vitro cement properties
    Verena Schnitzler, Franck Fayon, Christelle Despas, Ibrahim Khairoun, Charlotte Mellier, Thierry Rouillon, Dominique Massiot A, Alain Walcarius, Pascal Janvier, Olivier Gauthier et al. · 2010 · Acta Biomaterialia
  2. Bisphosphonate therapy in pediatric patients
    Guiti Z. Eghbali-Fatourechi · 2014 · Journal of Diabetes & Metabolic Disorders
  3. To stop or not to stop, that is the question
    Ego Seeman · 2008 · Osteoporosis International
  4. An in vitro Assay to Measure Targeted Drug Delivery to Bone Mineral
    Wolfgang Jahnke, Chrystèle Henry · 2010 · ChemMedChem
  5. Multimodal superparamagnetic nanoplatform for clinical applications: immunoassays, imaging & therapy
    Laurence Motte, Farah Benyettou, Caroline de Beaucorps, Marc Lecouvey, Irena Milošević, Yoann Lalatonne · 2010 · Faraday Discussions
  6. Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies
    Mikkel Bo Brent · 2023 · Pharmacology & Therapeutics
  7. The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing
    Matthew R. Allen · 2011 · Odontology
  8. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance
    Steven Boonen, Dirk Vanderschueren, Katrien Venken, Koen Milisen, M. Delforge, Patrick Haentjens · 2008 · Journal of Internal Medicine
  9. Direct Imaging of Nanoscale Dissolution of Dicalcium Phosphate Dihydrate by an Organic Ligand: Concentration Matters
    Lihong Qin, Wenjun Zhang, Jianwei Lu, Andrew G. Stack, Lijun Wang · 2013 · Environmental Science & Technology
  10. Structural Requirements for Bisphosphonate Binding on Hydroxyapatite: NMR Study of Bisphosphonate Partial Esters
    Elina Puljula, Petri A. Turhanen, Jouko Vepsäläinen, Maëlle Monteil, Marc Lecouvey, Janne Weisell · 2015 · ACS Medicinal Chemistry Letters
  11. NOFSA Guideline for the Diagnosis and Management of Osteoporosis
    Stephen F. Hough, Brynne H. Ascott-Evans, Susan L Brown, Bilkish Cassim, Tobie J. de Villiers, Stan Lipschitz, John Morley Pettifor, Ernst W.W. Sonnendecker · 2010 · Journal of Endocrinology Metabolism and Diabetes of South Africa
  12. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis
    Francisco Javier Manzano‐Moreno, Javier Ramos‐Torrecillas, Elvira De Luna‐Bertos, Concepción Ruíz, Olga García‐Martínez · 2014 · Journal of Cranio-Maxillofacial Surgery
  13. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading
    Anthony W. Feher, Andrew Koivunemi, Mark Koivunemi, Robyn K. Fuchs, David B. Burr, Roger J. Phipps, Susan Reinwald, Matthew R. Allen · 2009 · Bone
  14. Therapeutic strategies for treating osteolytic bone metastases
    Élise Verron, Heidy Schmid‐Antomarchi, Hugues Pascal‐Moussellard, Annie Schmid‐Alliana, Jean‐Claude Scimeca, Jean‐Michel Bouler · 2014 · Drug Discovery Today
  15. Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model
    Safra Rudnick‐Glick, Enav Corem‐Salkmon, Igor Grinberg, Shlomo Margel · 2016 · Journal of Nanobiotechnology
  16. Recovery of Trabecular and Cortical Bone Turnover After Discontinuation of Risedronate and Alendronate Therapy in Ovariectomized Rats
    Robyn K. Fuchs, Roger J. Phipps, David B. Burr · 2008 · Journal of Bone and Mineral Research
  17. Medical Potentialities of Biomimetic Apatites through Adsorption, Ionic Substitution, and Mineral/Organic Associations: Three Illustrative Examples
    Ahmed Al‐Kattan, Farid Errassifi, Anne‐Marie Sautereau, Stéphanie Sarda, Pascal Dufour, Allal Barroug, Isabelle Dos Santos, Christèle Combes, David Grossin, Christian C. Rey et al. · 2010 · Advanced Engineering Materials
  18. Renal safety of intravenous bisphosphonates in the treatment of osteoporosis
    Edward Michael Lewiecki, Paul D. Miller · 2007 · Expert Opinion on Drug Safety
  19. Bisphosphonates pharmacology and use in the treatment of osteoporosis
    Dima L. Diab, Nelson B. Watts, Paul D. Miller · 2020 · Elsevier eBooks
  20. Biomodulation of an implant for enhanced bone-implant anchorage
    Deepak Bushan Raina, David Larsson, Erdem Aras Sezgin, Hanna Isaksson, Magnus Tägil, Lars Lidgren · 2019 · Acta Biomaterialia
  21. Surface immobilized zoledronate improves screw fixation in rat bone: A new method for the coating of metal implants
    Therese Andersson, Fredrik Agholme, Per Aspenberg, Pentti Tengvall · 2010 · Journal of Materials Science Materials in Medicine
  22. Poly(γ-benzyl-l-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting
    Laura de Miguel, Magali Noiray, Georgiana G. Surpateanu, Bogdan Iuliu Iorga, Gilles Ponchel · 2013 · International Journal of Pharmaceutics
  23. Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
    Sonja Gamsjaeger, Birgit Buchinger, Ruth Zoehrer, Roger J. Phipps, Klaus Klaushofer A, Eleftherios P. Paschalis · 2011 · Bone
  24. Zoledronic acid in pediatric metabolic bone disorders
    Sasigarn Arunchaiya Bowden, John D. Mahan · 2017 · Translational Pediatrics
  25. Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate
    Socrates E. Papapoulos, Ralph C. Schimmer · 2007 · Postgraduate Medical Journal
  26. Bisphosphonates in Paget's disease
    Ian R. Reid, D. J. Hosking · 2010 · Bone
  27. Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients
    Qirui Ding, Jian Chen, Jin Fan, Qingqing Li, Guoyong Yin, Lipeng Yu · 2017 · European Spine Journal
  28. Lactobacillus rhamnosus GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice via gut-microbiota-dependent anti-inflammation
    Hao Liu, Ranli Gu, Wei Li, Wen Zhou, Zhe Cong, Jing Xue, Yunsong Liu, Qiang Wei, Yongsheng Zhou · 2019 · Therapeutic Advances in Chronic Disease
  29. Insight into the mechanism of three component condensation leading to aminomethylenebisphosphonates
    Ewa Dąbrowska, Agnieszka Z. Burzynska, Artur Mucha, Ewa Matczak‐Jon, Wanda Sawka‐Dobrowolska, Łukasz Berlicki, Pawel K. Kafarski · 2009 · Journal of Organometallic Chemistry
  30. An emulsification–solvent evaporation route to mesoporous bioactive glass microspheres for bisphosphonate drug delivery
    Min Cong Zhu, Jianlin Shi, Qianjun He, Lingxia Zhang, Feng Chen, Yu Chen · 2011 · Journal of Materials Science
  31. Effects of Intravenous Zoledronate on Bone Turnover and BMD Persist for at Least 24 Months
    Mark J Bolland, Andrew B. Grey, Anne M. Horne, Simon E. Briggs, Mark G Thomas, Rod B Ellis-Pegler, Karen E. Callon, Greg D. Gamble, Ian R. Reid · 2008 · Journal of Bone and Mineral Research
  32. Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
    Sonja Gamsjaeger, Birgit Hofstetter, Elisabeth Zwettler, Robert R. Recker, Jürg Andreas Gasser, Erik Fink Eriksen, Katharina Klaushofer, Eleftherios P. Paschalis · 2012 · Osteoporosis International
  33. Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice
    Toshihiro Sugiyama, Lee B. Meakin, Gabriel L. Galea, Brendan F. Jackson, Lance E. Lanyon, Frank H. Ebetino, R.G.G. Russell, J. S. Price · 2011 · Bone
  34. Influence of compatibilizing agent molecular structure on the mechanical properties of phosphate glass fiber‐reinforced PLA composites
    Papia Haque, Ian A. Barker, Andrew J. Parsons, Kristofer J. Thurecht, Ifty Ahmed, Gavin S. Walker, Chris D. Rudd, Derek J. Irvine · 2010 · Journal of Polymer Science Part A Polymer Chemistry
  35. Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?
    Élise Verron, Jean‐Michel Bouler · 2013 · Drug Discovery Today
  36. Alveolar bone and the bisphosphonates
    A. Cheng, CG Daly, RM Logan, Brian N. Stein, Alastair N. Goss · 2009 · Australian Dental Journal
  37. Role of zoledronic acid in the prevention and treatment of osteoporosis
    Louis‐Georges Ste‐Marie, Ages Rakel, Andrée Boucher, Louis‐Georges Ste‐Marie · 2011 · Clinical Interventions in Aging
  38. Paget disease: when to treat and when not to treat
    Frederick R. Singer · 2009 · Nature Reviews Rheumatology
  39. Effect of bisphosphonates on root resorption after tooth replantation – a systematic review
    Shariq Najeeb, Fahad Siddiqui, Zohaib Khurshid, Sana Zohaib, Muhammad Sohail Zafar, Shazia Akbar Ansari · 2016 · Dental Traumatology
  40. Smart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs
    Konstantinos E. Papathanasiou, Petri A. Turhanen, Stephan Ingmar Brückner, Eike Brunner, Konstantinos D. Demadis · 2017 · Scientific Reports
  41. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
    Yuki Ozaki, Masanori Koide, Yuriko Furuya, Tadashi Ninomiya, Hisataka Yasuda, Midori Nakamura, Yasuhiro Kobayashi, Naoyuki Takahashi, Nobuo Yoshinari, Nobuyuki Udagawa · 2017 · PLoS ONE
  42. Zoledronic Acid-containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor
    Xu Li, Solange A. Valdes, Riyad F. Alzhrani, Stephanie Hufnagel, Stephen David Hursting, Zhengrong Cui · 2019 · ACS Applied Materials & Interfaces
  43. Skeletal accumulation of bisphosphonates: implications for osteoporosis treatment
    Matthew R. Allen · 2008 · Expert Opinion on Drug Metabolism & Toxicology
  44. Tuning Dual-Drug Release from Composite Scaffolds for Bone Regeneration
    Paris, J.L., Román, J., Manzano, M., Cabañas, M.V., Vallet-Regí, M. · 2015 · International Journal of Pharmaceutics
  45. Recent advances on nanostructured biomaterials in osteosarcoma treatment
    Chengcheng Feng, Yechun Jiang, Tao Wang, Dasheng Tian, Cailiang Shen, Yuanying Wang, Haisheng Qian · 2023 · Coordination Chemistry Reviews
  46. Paget Disease of Bone
    Stuart L. Silverman · 2008 · JCR Journal of Clinical Rheumatology
  47. Fabrication of pluronic and methylcellulose for etidronate delivery and their application for osteogenesis
    Aparna Sai Laxmi Rangabhatla, Vimon Tantishaiyakul, Kwunchit Oungbho, Onpreeya Boonrat · 2015 · International Journal of Pharmaceutics
  48. Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy
    Brian A. Hain, B. Jude, Hai-Fang Xu, Dallas Smuin, Edward J. Fox, John C. Elfar, David L. Waning · 2020 · Journal of Bone and Mineral Research
  49. Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
    Kaleen N. Hayes, Elizabeth Martha Winter, Suzanne M. Cadarette, Andrea Michelle Burden · 2021 · Journal of Clinical Medicine
  50. Lowering Bone Mineral Affinity of Bisphosphonates as a Therapeutic Strategy to Optimize Skeletal Tumor Growth Inhibition In vivo
    Pierrick G.J. Fournier, Florence Daubiné, Mark Walden Lundy, Michael J. Rogers, Frank H. Ebetino, Philippe Clézardin · 2008 · Cancer Research
  51. Calcitonin: A useful old friend.
    Akash Srinivasan, Felyx Yat Kwong Wong, Dimitrios Karponis · 2020 · PubMed Central
  52. Synthesis and evaluation of new phosphonic, bisphosphonic and difluoromethylphosphonic acid monomers for dental application
    Yohann Catel, Vincent Besse, Anaïs Zulauf, David Marchat, Emmanuel Pfund, Thi‐Nhàn Pham, Didier Bernache‐Assollant, Michel Degrange, Thierry P. Lequeux, Pierre‐Jean Madec et al. · 2011 · European Polymer Journal
  53. Pathologic Fractures in Bisphosphonate-Related Osteonecrosis of the Jaw—Review of the Literature and Review of Our Own Cases
    Sven Otto, Christoph Pautke, Sigurd Hafner, Ronny Hesse, Lea Franziska Reichardt, Gerson Mast, Michael Ehrenfeld, Carl‐Peter Cornelius · 2013 · Craniomaxillofacial Trauma & Reconstruction
  54. Microstructure and properties of alendronate-loaded calcium phosphate cement
    Zhonghua Shen, Tao Yu, Jiandong Ye · 2014 · Materials Science and Engineering C
  55. Bisphosphonate Binding Affinity Affects Drug Distribution in Both Intracortical and Trabecular Bone of Rabbits
    John J. Turek, Frank H. Ebetino, Mark Walden Lundy, Shuting Sun, B. A. Kashemirov, Charles E. McKenna, Maxime A. Gallant, Lilian Irene Plotkin, Teresita Bellido, Xuchen Duan et al. · 2012 · Calcified Tissue International
  56. Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?
    Christian Horst Tonk, Sarah Hani Shoushrah, Patrick Babczyk, Basma El Khaldi-Hansen, Margit Schulze, Monika Herten, Edda Tobiasch · 2022 · International Journal of Molecular Sciences
  57. Phosphorus-containing SBA-15 materials as bisphosphonate carriers for osteoporosis treatment
    Montserrat Colilla, Isabel Izquierdo‐Barba, María Vallet‐Regí · 2010 · Microporous and Mesoporous Materials
  58. Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies
    Ian R. Reid · 2011 · Skeletal Radiology
  59. The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study
    Fatma Gossiel, C. Hoyle, Eugene Vincent McCloskey, K.E. Naylor, Jennifer Walsh, Nicola F. A. Peel, Richard Eastell · 2016 · Bone
  60. Antiresorption implant coatings based on calcium alendronate and octacalcium phosphate deposited by matrix assisted pulsed laser evaporation
    Elisa Boanini, Paola Torricelli, Lucia Forte, Stefania Pagani, Natalia Mihăilescu, Carmen Ristoscu, Ion Nicolae Mihailescu, Adriana Bigi · 2015 · Colloids and Surfaces B Biointerfaces
  61. Experimental results of combining bisphosphonates with allograft in a rat model
    Fredrik Agholme, Per Aspenberg · 2009 · Journal of Bone and Joint Surgery - British Volume
  62. Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality
    Marjolein C. H. van der Meulen, Adele L. Boskey · 2012 · Arthritis Research & Therapy
  63. Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate
    Hiroko Okawa, Takeru Kondo, Akishige Hokugo, Philip Cherian, Jesus J. Campagna, Nicholas A. Lentini, ERIC C. SUNG, ERIC C. SUNG, Samantha Chiang, Yi‐Ling Lin et al. · 2022 · eLife
  64. Diagnóstico e tratamento da osteoporose
    Márcio Passini Gonçalves de Souza · 2010 · Revista Brasileira de Ortopedia
  65. In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation
    Ulrike Kettenberger, Vera Luginbuehl, Philip Procter, Dominique P. Pioletti · 2015 · Journal of Tissue Engineering and Regenerative Medicine
  66. Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces
    Birgit Hofstetter, Sonja Gamsjaeger, Roger J. Phipps, Robert R. Recker, Frank H. Ebetino, Klaus Klaushofer A, Eleftherios P. Paschalis · 2012 · Journal of Bone and Mineral Research
  67. Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial
    Maurizio Rossini, Silvano Adami, Elena Fracassi, Ombretta Viapiana, Giovanni Orsolini, Maria Rosaria Povino, Luca Idolazzi, Davide Gatti · 2014 · Rheumatology International
  68. Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study
    Audrey Juillard, Guillaume Falgayrac, Bernard Cortet, Marie-Hélène Vieillard, Nathalie Azaroual, Jean‐Christophe Hornez, Guillaume Penel · 2010 · Bone
  69. Anticancer Properties of Zoledronic Acid
    Jonathan Green, Allan Lipton · 2010 · Cancer Investigation
  70. Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma
    Xin Huang, Wei Wu, Wenbo Yang, Xiangcheng Qing, Zengwu Shao · 2020 · Colloids and Surfaces B Biointerfaces
  71. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
    J. R. Curtis, Andrew O. Westfall, Hsinlin Thomas Cheng, Kenneth G. Saag, Elizabeth Delzell · 2008 · Osteoporosis International
  72. The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids
    Balooch, Guive, Yao, Wei, Ager, Joel W., Balooch, Mehdi, Nalla, Ravi K., Porter, Alexandra E., Ritchie, Robert O., Lane, Nancy E. · 2007 · Arthritis & Rheumatism
  73. Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
    Yoann Lalatonne, Maëlle Monteil, H. Jouni, Jean‐Michel Serfaty, Odile Sainte‐Catherine, Nicole Lievre, Sławomir Kuśmia, Pierre Weinmann, Marc Lecouvey, Laurence Motte · 2010 · Journal of Osteoporosis
  74. Vitamin D (25-OHD) deficiency may increase the prevalence of medication-related osteonecrosis of the jaw
    Nils Heim, Felix Benjamin Warwas, Christian Timm Wilms, Rudolf Hermann Reich, Markus Martini · 2017 · Journal of Cranio-Maxillofacial Surgery
  75. Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials
    Tiffany Y. Kim, Douglas C. Bauer, Brian McNabb, Anne L. Schafer, Felicia Cosman, Dennis M. Black, Richard Eastell · 2018 · Journal of Bone and Mineral Research
  76. Mesoporous silica-based hybrid materials for bone-specific drug delivery
    Luigi Pasqua, Ilaria Ester De Napoli, Marzia De Santo, Marianna Greco, Enrico Catizzone, Domenico Lombardo, Gabriella Montera, Alessandra Comandé, Alessandra Nigro, Catia Morelli et al. · 2019 · Nanoscale Advances
  77. Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study
    MASSIMO VARENNA, V. Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini · 2021 · Therapeutic Advances in Musculoskeletal Disease
  78. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys
    Yoshiki Yamagami, Tasuku Mashiba, Ken Iwata, Makoto Tanaka, Kazutoshi Nozaki, Tetsuji Yamamoto · 2013 · Bone
  79. Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy
    Agnieszka Majkowska‐Pilip, Maria Neves, Ines Farinha Antunes, Aleksander Bilewicz · 2008 · Applied Radiation and Isotopes
  80. Complexes of DOTA−Bisphosphonate Conjugates: Probes for Determination of Adsorption Capacity and Affinity Constants of Hydroxyapatite
    T. Vitha, Vojtěch Kubíček, Petr Hermann, Zvonimir I. Kolar, Hubert Th. Wolterbeek, Joop A. Peters, I. Lukeš · 2008 · Langmuir
  81. Oriented Immobilization of Proteins on Hydroxyapatite Surface Using Bifunctional Bisphosphonates as Linkers
    Jivan N. Yewle, Yinan Wei, David A. Puleo, Sylvia Daunert, Leonidas G. Bachas · 2012 · Biomacromolecules
  82. Clinical role of bisphosphonate therapy
    Ignac Fogelman, Hampson · 2012 · International Journal of Women s Health
  83. Antiresorptive and anti-angiogenetic octacalcium phosphate functionalized with bisphosphonates: An in vitro tri-culture study
    Lucia Forte, Paola Torricelli, Elisa Boanini, Massimo Gazzano, Milena Fini, Adriana Bigi · 2017 · Acta Biomaterialia
  84. Attenuating osteoarthritis by a high efficient anti-bone resorption injectable pH-responsive bisphosphonate-conjugated nano-apatite system
    Zhen Geng, Xiaogang Wang, Yuanman Yu, Luli Ji, Jing Wang, Changsheng Liu · 2020 · Chemical Engineering Journal
  85. Recent Progress in the Solid-State NMR Studies of Biomineralization
    Tim W. T. Tsai, Jerry C. C. Chan · 2011 · Annual reports on NMR spectroscopy
  86. Microwave-assisted synthesis of nitrogen-containing 1-hydroxymethylenebisphosphonate drugs
    Dana A. Mustafa, B. A. Kashemirov, Charles E. McKenna · 2011 · Tetrahedron Letters
  87. Do Estrogen and Alendronate Improve Metaphyseal Fracture Healing When Applied as Osteoporosis Prophylaxis?
    Leila Kolios, Ann Kristin Hoerster, Stephan Sehmisch, Marie Christin Malcherek, Thomas Rack, M. Tezval, Dana Seidlová‐Wuttke, W. Wuttke, Klaus Michael Stürmer, Ewa K. Stuermer · 2009 · Calcified Tissue International
  88. Facile Synthesis of Octacalcium Phosphate Nanobelts: Growth Mechanism and Surface Adsorption Properties
    Xianyan Yang, Xin Gao, Yilai Gan, Changyou Gao, Xinli Zhang, Kang Ting, Benjamin M. Wu, Zhongru Gou · 2010 · The Journal of Physical Chemistry C
  89. Protonation State and Hydration of Bisphosphonate Bound to Farnesyl Pyrophosphate Synthase
    Takeshi Yokoyama, Mineyuki Mizuguchi, Andreas Ostermann, Katsuhiro Kusaka, Nobuo Niimura, Tobias E. Schrader, Ichiro Tanaka · 2015 · Journal of Medicinal Chemistry
  90. Bisphosphonate Therapy and Atypical Fractures
    Anas Saleh, Vishal V. Hegde, Anish G. R. Potty, Joseph M. Lane · 2013 · Orthopedic Clinics of North America
  91. Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond
    Joanna Gałęzowska · 2018 · ChemMedChem
  92. Calcium Orthophosphate (CaPO4) Scaffolds for Bone Tissue Engineering Applications
    Sergey V. Dorozhkin · 2018 · Journal of Biotechnology and Biomedical Science
  93. Hydrophosphonylation of alkenes or nitriles by double radical transfer mediated by titanocene/propylene oxide
    Camille Midrier, Mathias Lantsoght, Jean‐Noël Volle, Jean‐Luc Pirat, David Virieux, Christian Victor Stevens · 2011 · Tetrahedron Letters
  94. Affinity of hydroxyapatite (001) and (010) surfaces to formic and alendronic acids: a quantum-mechanical and infrared study
    Pieremanuele Canepa, Fabio Chiatti, Marta Corno, Yuriy E. Sakhno, Gianmario Martra, Piero Ugliengo · 2010 · Physical Chemistry Chemical Physics
  95. Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis
    Kazuaki Niikura · 2006 · Cancer Chemotherapy and Pharmacology
  96. A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro
    Brian M. Wasko, Jacqueline P. Smits, Larry W. Shull, David F. Wiemer, Raymond J. Hohl · 2011 · Journal of Lipid Research
  97. An insight into recent developments in imidazole based heterocyclic compounds as anticancer agents: Synthesis, SARs, and mechanism of actions
    Arun Kumar, Anjali Kaushal, Prabhakar Kumar Verma, Manoj K. Gupta, Girish Chandra, Umesh Kumar, Ashok Kumar Yadav, Deepak Kumar · 2024 · European Journal of Medicinal Chemistry
  98. Bisphosphonate prodrugs: Synthesis and biological evaluation in HuH7 hepatocarcinoma cells
    Maëlle Monteil, Evelyne Migianu‐Griffoni, Odile Sainte‐Catherine, Mélanie Di Benedetto, Marc Lecouvey · 2014 · European Journal of Medicinal Chemistry
  99. Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
    Gianfranco Favia, Angela Tempesta, Luisa Limongelli, Vito Crincoli, Eugenio Maiorano · 2016 · International Journal of Dentistry
  100. Sequential Delivery of Doxorubicin and Zoledronic Acid to Breast Cancer Cells by CB[7]-Modified Iron Oxide Nanoparticles
    Farah Benyettou, Marwa Alhashimi, Matthew John O’Connor, Renu Pasricha, Jérémy Brandel, Hassan Traboulsi, Javed Mazher, John‐Carl Olsen, Ali Trabolsi · 2017 · ACS Applied Materials & Interfaces